Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,758 | 530 | 98.8% |
| Education | $71.40 | 4 | 0.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,236 | 168 | $0 (2024) |
| Janssen Biotech, Inc. | $868.50 | 55 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $822.32 | 65 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $605.07 | 42 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $387.83 | 23 | $0 (2024) |
| PFIZER INC. | $280.38 | 17 | $0 (2024) |
| Braintree Laboratories, Inc. | $267.62 | 19 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $227.32 | 14 | $0 (2017) |
| Allergan Inc. | $210.01 | 19 | $0 (2019) |
| QOL Medical, LLC | $158.09 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,322 | 77 | ABBVIE INC. ($295.50) |
| 2023 | $1,360 | 88 | AbbVie Inc. ($382.31) |
| 2022 | $962.38 | 72 | ABBVIE INC. ($234.20) |
| 2021 | $495.87 | 35 | AbbVie Inc. ($169.45) |
| 2020 | $230.53 | 15 | AbbVie Inc. ($74.97) |
| 2019 | $1,056 | 84 | AbbVie, Inc. ($281.43) |
| 2018 | $1,055 | 83 | AbbVie, Inc. ($325.42) |
| 2017 | $1,368 | 81 | AbbVie, Inc. ($472.70) |
All Payment Transactions
535 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/09/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Rare Disease | ||||||
| 12/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: LIVER DISEASE | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: LIVER DISEASE | ||||||
| 11/18/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug), SUTAB | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: GI COLON PREP | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.80 | General |
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/15/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Immunology | ||||||
| 10/10/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.77 | General |
| Category: GI | ||||||
| 10/07/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $20.44 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/30/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $20.77 | General |
| Category: GI | ||||||
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Gastroenterology | ||||||
| 09/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/13/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Immunology | ||||||
| 09/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Education | In-kind items and services | $8.45 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 449 | 483 | $419,224 | $54,059 |
| 2022 | 8 | 314 | 377 | $258,523 | $34,635 |
| 2021 | 8 | 323 | 395 | $162,645 | $39,655 |
| 2020 | 8 | 270 | 330 | $150,843 | $31,113 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 120 | $41,880 | $12,332 | 29.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 88 | 88 | $159,720 | $12,276 | 7.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 64 | 68 | $108,460 | $7,389 | 6.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 27 | 27 | $51,233 | $6,133 | 12.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $18,920 | $6,038 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 71 | $16,685 | $4,622 | 27.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 33 | 33 | $11,616 | $2,316 | 19.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $6,570 | $1,707 | 26.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 18 | $4,140 | $1,246 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 119 | $38,451 | $10,012 | 26.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 46 | 46 | $82,318 | $5,700 | 6.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 59 | 69 | $15,450 | $4,486 | 29.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 41 | 45 | $69,546 | $4,377 | 6.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $15,260 | $4,098 | 26.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 12 | 12 | $22,770 | $2,459 | 10.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $9,402 | $2,180 | 23.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 24 | $5,326 | $1,324 | 24.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 108 | $21,060 | $11,615 | 55.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 46 | 46 | $13,800 | $6,556 | 47.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 41 | 41 | $52,661 | $5,255 | 10.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 49 | 51 | $48,052 | $5,247 | 10.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 64 | $9,600 | $4,307 | 44.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 26 | 50 | $7,442 | $3,123 | 42.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 19 | 20 | $6,280 | $2,322 | 37.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $3,750 | $1,231 | 32.8% |
About Dr. Aaron Bellows, M.D
Dr. Aaron Bellows, M.D is a Gastroenterology healthcare provider based in Princeton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2011. The National Provider Identifier (NPI) number assigned to this provider is 1689964546.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Bellows, M.D has received a total of $7,850 in payments from pharmaceutical and medical device companies, with $1,322 received in 2024. These payments were reported across 535 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($7,758).
As a Medicare-enrolled provider, Bellows has provided services to 1,356 Medicare beneficiaries, totaling 1,585 services with total Medicare billing of $159,462. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Princeton, NJ
- Active Since 04/13/2011
- Last Updated 09/23/2014
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1689964546
Products in Payments
- STELARA (Biological) $770.30
- Humira (Biological) $683.81
- XIFAXAN (Drug) $637.76
- RINVOQ (Biological) $455.13
- Linzess (Drug) $335.70
- HUMIRA (Biological) $283.39
- ENTYVIO (Biological) $265.94
- XELJANZ (Drug) $246.59
- SKYRIZI (Biological) $243.86
- ZENPEP (Drug) $218.02
- IBSRELA (Drug) $154.03
- Amitiza (Drug) $144.99
- RELISTOR ORAL (Drug) $142.18
- VIBERZI (Drug) $139.59
- Creon (Drug) $139.53
- Mavyret (Drug) $137.50
- Entyvio (Biological) $132.29
- REMICADE (Biological) $130.41
- LINZESS (Drug) $119.82
- EXALT Model D (Device) $118.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Princeton
Dr. Anish Sheth, Md, MD
Gastroenterology — Payments: $205,196
Amy Shriver, M.d, M.D
Gastroenterology — Payments: $86,913
Glenn Osias, Md, MD
Gastroenterology — Payments: $13,027
Robert Meirowitz, Md, MD
Gastroenterology — Payments: $7,725
Aloysius Rho, Md, MD
Gastroenterology — Payments: $7,329
Dr. Darren Andrade, M.d, M.D
Gastroenterology — Payments: $5,859